Search

everythinglearnresearchcommunity

for

Search:↓

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Cyproterone acetate works similarly to other treatments for hirsutism, but more research is needed.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Tribulus terrestris may protect the liver from drug damage.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

A patient with complete hair loss regrew all her hair using tofacitinib.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Oral etretinate improved hair length and reduced beading in monilethrix.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Adding zinc to pyrithione zinc improves its effectiveness against scalp conditions like dandruff.

GD-23 reduces anxiety by relying on neurosteroid production.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.